logo
Book a meeting
Bioresponse

Bioresponse

Health, Wellness And Fitness, Po Box 288, Boulder, Colorado, 80306, United States, 1-10 Employees

bioresponse.com

  • facebook
  • LinkedIn

phone no Phone Number: 30********

Who is BIORESPONSE

BioResponse Nutrients, LLC is the originator and patent holder for microencapsulated Diindolylmethane. (BioResponse DIM). Our mission since 1998 has been our commitment to research the pr...

Read More

lock icon Get Full Access
map
  • Po Box 288, Boulder, Colorado, 80306, United States Headquarters: Po Box 288, Boulder, Colorado, 80306, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million

industries-icon Industry: Health, Wellness and Fitness

SIC SIC Code: 2023 | NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIORESPONSE

Bioresponse Org Chart and Mapping

Employees
Daniel Almond

Daniel Almond

Operations Manager

Evan Cormane

Evan Cormane

Warehouse and Sales Associate

Ryan Domocmat

Ryan Domocmat

Quality Assurance

See Full Org Chart arrow
email-formate-icon
View Email Formats for Bioresponse
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Bioresponse

Answer: Bioresponse's headquarters are located at Po Box 288, Boulder, Colorado, 80306, United States

Answer: Bioresponse's phone number is 30********

Answer: Bioresponse's official website is https://bioresponse.com

Answer: Bioresponse's revenue is $1 Million to $5 Million

Answer: Bioresponse's SIC: 2023

Answer: Bioresponse's NAICS: 621111

Answer: Bioresponse has 1-10 employees

Answer: Bioresponse is in Health, Wellness and Fitness

Answer: Bioresponse contact info: Phone number: 30******** Website: https://bioresponse.com

Answer: BioResponse Nutrients, LLC is the originator and patent holder for microencapsulated Diindolylmethane. (BioResponse DIM). Our mission since 1998 has been our commitment to research the present nutraceutical and future therapeutic uses of DIM. Michael A. Zeligs, M.D., CEO and Founder, pioneered the commercialization of DIM and was the first to ever develop bioavailable microencapsulated diindolylmethane (DIM) for human use.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access